From October 1, 2023 to December 31, 2023, the company has repurchased 123,562 shares, representing 4.08% for $0.19 million. With this, the company has completed the repurchase of 252,855 shares, representing 8.21% for $0.47 million under the buyback announced on January 31, 2023.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.98 USD | -0.83% |
|
-10.91% | -31.94% |
06-11 | Silo Pharma, Inc. announced that it has received $2.077409 million in funding | CI |
06-07 | Silo Pharma Close to Achieving Optimal Formulation for Ketamine Implant | MT |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-31.94% | 3.64M | |
+2.22% | 93.53B | |
-1.32% | 38.27B | |
-13.44% | 32.84B | |
+76.30% | 27.83B | |
-13.11% | 16.08B | |
+0.68% | 14.02B | |
-12.06% | 11.47B | |
+185.28% | 9.92B | |
-53.00% | 9.42B |
- Stock Market
- Equities
- SILO Stock
- News Silo Pharma, Inc.
- Tranche Update on Silo Pharma, Inc.'s Equity Buyback Plan announced on January 31, 2023.